Neither surgical nor cotton masks effectively filter Covid 19 virus: study Hina Zahid7 April 2020 4:45 PM ISTUSA: The efficacy of surgical and cotton masks in the growing coronavirus battle is often debated in the medical fraternity. Masks are considered must...
Isradipine does not slow clinical progression of Parkinson's disease Dr. Kamal Kant Kohli6 April 2020 9:00 AM ISTIn epidemiologic studies, dihydropyridine calcium-channel blockers have been associated with reduced risk for Parkinson's disease (PD). The...
Woman develops Asthma after pacemaker implantation: case report Dr. Kamal Kant Kohli31 March 2020 6:00 PM ISTClinicians from Ozarks Medical Center in West Plains, Missouri have reported a case of a 58-year-old woman who developed Asthma after implantation of...
Apixaban bests rivaroxaban for prevention of stroke in AF Dr. Kamal Kant Kohli11 March 2020 6:15 PM ISTThe blood thinner apixaban may be safer and more effective than rivaroxaban in preventing strokes and systemic blood clots in patients with atrial...
Alirocumab may cause scleritis with uveal effusion in susceptible patients Dr. Kamal Kant Kohli10 March 2020 1:00 PM ISTAlirocumab has been linked to scleritis with uveal effusion in patient with autoimmune diseases according to a case study. In the literature...
No death benefit from continued mammography screening beyond 75 years Dr. Kamal Kant Kohli25 Feb 2020 6:48 PM ISTIt is an important question in breast cancer screening at what age it should be stopped.This is a very pertinent question in breast cancer...
Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea: VA/DoD guidelines Dr. Kamal Kant Kohli19 Feb 2020 3:24 PM ISTSAN ANTONIO - The U.S. Departments of Veterans Affairs and Defense (VA/DoD) jointly have issued new guidelines for assessment and treatment of...
Low-dose methotrexate linked to increased adverse events in some Dr. Kamal Kant Kohli18 Feb 2020 4:56 PM ISTUSA: Methotrexate is the most commonly used drug for systemic rheumatic diseases worldwide and the recommended first-line agent for rheumatoid...
